Caxton Associates LP Omnicell, Inc Transaction History

Caxton Associates LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$26.15 - $37.33 $521,666 - $744,696	-19,949 Reduced 35.5%	36,244 $1.06 Million
Q4 2023 Feb 14, 2024	BUY	$29.24 - $45.81 $1.64 Million - $2.57 Million	56,193 New	56,193 $2.11 Million
Q3 2022 Nov 14, 2022	BUY	$84.23 - $117.38 $537,471 - $749,001	6,381 New	6,381 $555,000
Q3 2019 Nov 14, 2019	SELL	$68.36 - $88.34 $277,609 - $358,748	-4,061 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$58.88 - $86.19 $239,111 - $350,017	4,061 New	4,061 $328,000

276

43.8M

224K

35.7K

Ticker OMCL
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 44,288,800
Market Cap $1.99B
Description
Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensi...

Get notified when there are updates to the investment portfolio of Caxton Associates LP, based on Form 13F filings with the SEC.

Stay updated on Caxton Associates LP with notifications on news.